Mechanisms of action of Bcl-2 family proteins

Aisha Shamas-Din1, Justin Kale, Brian Leber

  • 1Department of Biochemistry and Biomedical Sciences, McMaster University, Hamilton, Ontario L8S4K1, Canada.

Insights

The Bcl-2 protein family regulates apoptosis by controlling mitochondrial outer membrane permeabilization (MOM). Their interactions, influenced by concentration and binding affinity, modulate cell death.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Biochemistry

Background:

  • The Bcl-2 protein family is crucial for regulating apoptosis, a key cellular process.
  • This family controls mitochondrial outer membrane permeabilization (MOM), a critical step in apoptosis.
  • Existing models for Bcl-2 protein interactions are complex and varied.

Purpose of the Study:

  • To rationalize existing models of Bcl-2 protein interactions.
  • To explore the role of protein concentration and binding affinity in regulating apoptosis.
  • To investigate how dynamic interactions and conformational changes influence Bcl-2 protein function.

Main Methods:

  • Analysis of existing experimental data on Bcl-2 protein interactions.
  • Integration of findings regarding interactions in both cytoplasmic and membrane environments.
  • Consideration of protein concentrations and relative binding affinities.

Main Results:

  • Bcl-2 protein interactions occur in both cytoplasm and membranes.
  • Protein concentrations and binding affinities are key determinants of these interactions.
  • Dynamic interactions lead to conformational changes that modulate apoptotic function.

Conclusions:

  • A new framework is proposed for rationalizing models of Bcl-2 protein interactions.
  • Understanding these dynamic interactions provides insights into apoptosis regulation.
  • Conformational changes driven by interactions offer potential regulatory mechanisms for apoptosis.

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Cellular Injury V: Apoptosis and Autophagy01:22

Cellular Injury V: Apoptosis and Autophagy

Cells respond to damage and stress through highly coordinated processes that decide whether they survive or undergo controlled self-destruction. Two major pathways involved in this regulation are apoptosis, a type of programmed cell death, and autophagy, a survival mechanism that helps cells adapt to adverse conditions.ApoptosisApoptosis removes aged or injured cells to maintain tissue balance. During this process, the cell shrinks, chromatin condenses and fragments, and membrane-bound...